Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

Rita E. Chen(Washington University in St. Louis), Michael Diamond(Washington University in St. Louis), Jane A. O’Halloran(St. Vincent's University Hospital), Wooseob Kim(Korea University), Xuping Xie(The University of Texas Medical Branch at Galveston), Adrianus C. M. Boon, Ali H. Ellebedy(Washington University in St. Louis), Alfred H.J. Kim(Unknown), Pavlo Gilchuk(Vanderbilt University Medical Center), Laura A. VanBlargan(Washington University in St. Louis), James Brett Case(Washington University in St. Louis), Herbert W. Virgin(Southwestern Medical Center), Rachel M. Presti(Johns Hopkins University), Aaron J. Schmitz(Washington University in St. Louis), James E. Crowe(Vanderbilt University Medical Center), Naveenchandra Suryadevara(Vanderbilt University), Pei‐Yong Shi(The University of Texas Medical Branch at Galveston), Lindsay Droit(Washington University in St. Louis), Daved H. Fremont(Washington University in St. Louis), Dora Pinto(Unidade Local de Saúde de São José), Jackson S. Turner(Washington University in St. Louis), Mahima Thapa(Washington University in St. Louis), John M. Errico(Washington University in St. Louis), Seth J. Zost(Vanderbilt University Medical Center), Stephen Tahan(Washington University in St. Louis), Yang Liu(Shenzhen Bay Laboratory), David Wang(Washington University in St. Louis), Jianying Liu(The University of Texas Medical Branch at Galveston), Emma S. Winkler(Washington University in St. Louis), Davide Corti(Vir Biotechnology (Switzerland)), Xianwen Zhang(Hunan Agricultural University), Parakkal Deepak(Washington University in St. Louis)
Nature Medicine
March 4, 2021
Cited by 1,016


Related Papers